Talaris Therapeutics

About:

Talaris Therapeutics is a operator of a biotechnology company engaged in the development of innovative cellular therapies.

Website: https://talaristx.com/

Twitter/X: TalarisTx

Top Investors: BlackRock, Qiming Venture Partners, Invus, Cormorant Asset Management, Viking Global Investors

Description:

Talaris Therapeutics is a operator of a biotechnology company engaged in the development of innovative cellular therapies. The company's proprietary allogeneic cell therapy product has shown to induce tolerance in recipients of solid organ transplants from unmatched and unrelated donors, enabling living donor kidney transplant recipients to wean completely off immunosuppression one year after transplant.

Total Funding Amount:

$215M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Louisville, Kentucky, United States

Founded Date:

2002-01-01

Contact Email:

info(AT)talaristx.com

Founders:

Number of Employees:

101-250

Last Funding Date:

2020-10-06

IPO Status:

Public

Industries:

© 2025 bioDAO.ai